Evolent Health, Inc.
EVHNYSEHealthcare● Active
$4.76
+$0.54(+12.68%)
Market Cap$534847474
P/E Ratio—
52W High$12.065
52W Low$2.095
Evolent Health, Inc. (EVH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EVH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $0.91B |
| Cost of Revenue | $1.59B | $2.19B | $1.50B | $1.04B | $0.66B |
| Gross Profit | $0.28B | $0.37B | $0.46B | $0.32B | $0.25B |
| Gross Margin %(computed) | 15.14% | 14.38% | 23.45% | 23.42% | 27.58% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.03B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.22B |
| Total Operating Expenses | $0.29B | $0.41B | $0.53B | $0.31B | $0.29B |
| Operating Income | ($0.00B) | ($0.04B) | ($0.07B) | $0.00B | ($0.04B) |
| Operating Margin %(computed) | -0.24% | -1.58% | -3.63% | 0.27% | -4.67% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.06B | $0.02B | $0.05B | $0.02B | $0.03B |
| Income Before Tax | ($0.53B) | ($0.06B) | ($0.20B) | ($0.06B) | ($0.03B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.09B) | ($0.04B) | $0.00B |
| Net Income | ($0.53B) | ($0.06B) | ($0.11B) | ($0.02B) | ($0.04B) |
| Net Margin %(computed) | -28.49% | -2.41% | -5.76% | -1.42% | -4.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.36 |
| Wtd Avg Shares | 0.11B | 0.11B | 0.11B | 0.09B | 0.09B |
| EBITDA | $0.11B | $0.08B | ($0.02B) | $0.04B | $0.06B |
| EBITDA Margin %(computed) | 5.94% | 3.32% | -1.26% | 3.24% | 6.13% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Evolent Health, Inc. data
About Evolent Health, Inc. (EVH) Income Statement
Evolent Health, Inc. (EVH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EVH reported revenue of $1.88B, gross profit of $0.28B (gross margin 15.14%), and net income of ($0.53B) — a net profit margin of -28.49%.
Frequently asked questions
EVH · 4 questionsEvolent Health, Inc. (EVH) reported revenue of $1.88B for 2025, down 26.6% year-over-year.
EVH revenueEVH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08